Clinical trial
A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of…
NCT00463918 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00463918 |
|---|---|
| Title | A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers |
| Official title | Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Multiple-Dose Pharmacokinetics, Safety and Tolerability of Varenicline in Healthy Adolescent Smokers |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | varenicline |
| Enrollment | 73 |
| Start date | May 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 20, 2007 |
| Last update posted | Nov 19, 2008 |
| Countries | United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: